Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Recap: Verrica Pharmaceuticals Q1 Earnings

Verrica Pharmaceuticals (NASDAQ:VRCA) reported its Q1 earnings results on Tuesday, May 9, 2023 at 07:30 AM. Here's what investors need to know about the announcement.
byBenzinga Insights
May 9, 2023
1 minute read
Total
0
Shares
0
0
0
0
0
0

Verrica Pharmaceuticals (NASDAQ:VRCA) reported its Q1 earnings results on Tuesday, May 9, 2023 at 07:30 AM.

Here’s what investors need to know about the announcement.

Earnings

Verrica Pharmaceuticals beat estimated earnings by 31.58%, reporting an EPS of $-0.13 versus an estimate of $-0.19.

Revenue was down $394 thousand from the same period last year.

Past Earnings Performance

Last quarter the company beat on EPS by $0.05 which was followed by a 7.7% drop in the share price the next day.

Listen to the earnings announcement yourself by clicking here.

To track all earnings releases for Verrica Pharmaceuticals visit their earnings calendar here.

This article was generated by Benzinga’s automated content engine and reviewed by an editor.

 
Total
0
Shares
Share 0
Tweet 0
Share 0
Share 0
Share 0
Share 0
Related Posts
Read More

Everest Re Group: Q2 Earnings Insights

By Benzinga Insights
July 27, 6:01 PM
Everest Re Group (NYSE:RE) reported its Q2 earnings results on Wednesday, July 27, 2022 at 04:15 PM. Here's what investors need to know about the announcement. Earnings Everest Re Group beat estimated earnings by 39.46%, reporting an EPS of $9.79 versus an estimate of $7.02.

RE